The QualityStocks Daily Thursday, December 16th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(KXIN) $1.6900 +36.29%

Daily Trade Alert(DPUKY) $11.4100 +22.95%

SeriousTraders(SBEV) $1.2200 +17.31%

The QualityStocks Daily Stock List


QualityStocks, Wall Street Mover, Promotion Stock Secrets, TopPennyStockMovers, StreetAuthority Daily, MarketBeat and Jason Bond reported earlier on WEED, Inc. (BUDZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

WEED, Inc. is a multi-national, multi-faceted, vertically integrated cannabis company. It is structured as a holding company doing business by way of its divisions, wholly-owned subsidiaries, and strategically placed collaborative partners to attain and promote its worldwide agenda and brand. Established in 1999, WEED has its head office in Tucson, Arizona.

The Company previously went by the name United Mines, Inc. It changed its corporate name to WEED, Inc. in February of 2015. The Company’s shares trade on the OTC Markets Group’s OTCQB.

WEED’s subsidiaries include Sangre BioSciences; Weed Australia Ltd.; WEED Israel Cannabis Ltd.; The Hemp Institute of Arizona; and The Cannabis Institute of Australia. Sangre BioSciences is in the process of conducting a comprehensive Cannabis Genome Study to complete an international genomic classification of the cannabis plant genus.

WEED Australia Ltd.’s strategy is to use its proprietary research, medical patents, and clinical trials to create innovative medical products and services for the treatment of human and animal diseases. WEED Israel Cannabis Ltd. was founded to build and expand WEED, Inc.’s worldwide presence. In support of WEED Israel Cannabis Ltd., WEED, Inc. has entered into an exclusive license and assignment agreement with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Israel. This agreement is for five patents, technology, as well as knowledge regarding formulations for the administration and delivery of cannabinoid compounds.

The Hemp Institute of Arizona was created by WEED, Inc. to research and study the hemp plant, industrial and CBD (cannabidiol) strains, to create forward-looking cultivation techniques and to find new methods of extracting CBD compounds for use in medical applications. The Cannabis Institute of Australia was established by WEED Australia Ltd. as its non-profit division in March of 2018 with the aim of creating a Scientific Advisory Council to establish national protocols and procedures backed by scientific research.

WEED, Inc. (BUDZ), closed Thursday’s trading session at $0.41, up 32.2581%, on 1,142,111 volume. The average volume for the last 3 months is 1.142M and the stock's 52-week low/high is $0.213/$2.68.

Kaixin Auto Holdings (KXIN)

MarketClub Analysis, StockMarketWatch, QualityStocks, TradersPro, Trades Of The Day, The Street, MarketBeat and InvestorPlace reported earlier on Kaixin Auto Holdings (KXIN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kaixin Auto Holdings (NASDAQ: KXIN) (FRA: K64) is a holding company which also operates as an investment firm. The firm’s subsidiaries operate or own used car dealerships and the company is among the main dealership networks in the premium used car segment in China.

Formerly known as CM Seven Star Acquisition Corp., Kaixin Auto Holdings is based in Beijing in the People’s Republic of China and was founded in 2015. The firm is a Renren Inc. subsidiary and focuses on car brands like Porsche, Land Rover, Mercedes-Benz, BMW and Audi.

Kaixin Auto Holdings’ operating segment is inclusive of automobile sales. Geographically speaking, the firm derives its revenue from China. However, the majority of Kaixin Auto’s revenue is generated from the automobile sales segment; the sale of used cars and fees received for the role the firm plays as a channel partner for 3rd party auto financing.

Kaixin Auto Holdings provides value-added services such as after sales services, extended warranties and insurance to its consumers. Additionally, it offers financing channels to its consumers through its collaborations with financial institutions.

Kaixin Auto Holdings recently announce its purchase agreement with Haitaoche Ltd shareholders. Haitaoche is an online retail platform that imports automobiles and with the used car market in China continuing to grow rapidly combined with this partnership, the firm’s sales are bound to increase, which will prompt further growth and good returns.

Kaixin Auto Holdings (KXIN), closed Thursday’s trading session at $1.69, up 36.2903%, on 89,104,312 volume. The average volume for the last 3 months is 88.164M and the stock's 52-week low/high is $1.15/$5.49.

Aptose Biosciences (APTO)

StockMarketWatch, MarketBeat,, Schaeffer's, MarketClub Analysis, StreetInsider, TradersPro, Investing Futures, Daily Trade Alert, Zacks, Trading Concepts, QualityStocks, Kiplinger Today, Jason Bond and BUYINS.NET reported earlier on Aptose Biosciences (APTO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aptose Biosciences Inc. (NASDAQ: APTO) (TSE: APS) (FRA: LTIA) is a clinical stage biotechnology firm that is engaged in the discovery and development of personalized therapies that address various unmet clinical oncological needs in the U.S.

The firm has its headquarters in Toronto, Canada and was founded in 1986. It serves consumers in Canada and has offices in both Toronto and San Diego. Prior to its name change in August 2014, the firm was known as Lorus Therapeutics Inc.

The enterprise develops anticancer drugs that target signal transduction abnormalities and particular epigenetic processes that underlie various life-threatening malignancies. It is party to an agreement with OHM Oncology, which entails developing, manufacturing and commercializing a protein and kinase inhibitor program dubbed APL-581. In addition to this, it is also party to an agreement with Crystal Genomics Inc. for the research, development and commercialization of CG-806 and CG026806, which are undergoing phase 1 clinical trials for the treatment of relapsed/refractory acute myeloid leukemia, certain non-Hodgkin’s lymphomas, small lymphocytic lymphoma and chronic lymphocytic leukemia.

The company’s clinical programs include a formulation dubbed APTO-253, which is currently in a phase 1a/b clinical trial testing its effectiveness in treating patients with refractory or relapsed blood cancers, and these include high-risk myelodysplastic syndrome and acute myeloid leukemia.

The firm initiated 3 clinical trials which are all underway, one of which focuses on their APTO-253 candidate while the remaining two are focused on their CG-806 candidate. It expects successful results from all studies, given the indicators observed in CG-806’s safety profile and anti-cancer activity. Good results will boost investments into the firm, which will be beneficial to stakeholders.

Aptose Biosciences (APTO), closed Thursday’s trading session at $1.47, up 23.5294%, on 8,426,506 volume. The average volume for the last 3 months is 8.427M and the stock's 52-week low/high is $1.08/$7.20.

Grow Solutions Holdings, Inc. (GRSO)

Profitable Trader Authority, QualityStocks, PennyStockScholar, OTCtipReporter, StockRockandRoll, ResearchOTC,, Journal Transcript, Stockgoodies, InvestorPlace and Elite Stock Alerts reported earlier on Grow Solutions Holdings, Inc. (GRSO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Grow Solutions Holdings, Inc. provides total support services in the broad area of high-yield indoor agriculture. The Company specializes in, but is not limited to, the legal and regulated growing and processing of cannabis. Its mission is to be recognized as the world’s foremost authority in the indoor high-yield agriculture industry. Formed in 2014, Grow Solutions Holding’s is based in Denver, Colorado.

Fundamentally, Grow Solutions centers on the development/distribution of high-demand products and services for cultivation, processing, as well as consumption of cannabis. Its diversified platform of operations and services for the industry consists of its Growth Technologies division (products needed to grow cannabis in and outside), its Consumer Technologies division (products to process, store and consume cannabis), and its Digital Properties division (online properties, including a state-of-the-art employment platform).   

Grow Solutions Holdings acquired (in May of 2015) Boulder, Colorado-based One Love Garden Supply. One Love is a full-service garden and grow store that Grow Solutions expanded to greater than 7,000 square feet of space.   

Additionally, in September of 2015, Grow Solutions acquired HyGrow. This acquisition is to expand its gardening supplies and agricultural products business. This acquisition enabled the Company to expand into Denver and Pueblo, Colorado.   

Grow Solutions has developed and launched FutureTech Products of Pompano, Florida.  FutureTech develops products for the consumer market to sell in smoke shops, head shops, and dispensaries.

Grow Solutions also acquired Keys Organic and Hydroponic Supply (Keys) in Florida. This acquisition of Keys expands on Grow Solutions’ existing operations in the southeast via its Future Tech division through providing a strategic location for the entry of its One Love Garden Supply subsidiary into east coast markets.

Furthermore, Grow Solutions acquired Mile High Hydro. This is a full service online grow store. It offers an extensive line of gardening supply and agricultural products to growers throughout the nation. Grow Solutions also acquired West Coast Organic and Hydroponic Supply (WCO) in Boring, Oregon.

Grow Solutions’ retail sales division uses Company funds for the acquisition of retail stores. These are stores that have shown significant presence in strategic locations.

Concerning the Company’s distribution division, it will allocate Company funds towards the manufacturing of proprietary products, bulk purchasing of a variety of products and technologies, warehousing, and the distribution and wholesale of these products to Grow Solutions retailers serving the indoor high-yield agriculture industry.

Grow Solutions’ Services division comprises Management and Consulting, Financing, Licensing, and Real Estate. Pertaining to Real Estate, the Company will acquire real estate and master leases then lease the properties to professional growers in different aspects of the indoor high-yield agriculture industry.

Grow Solutions Holdings, Inc. (GRSO), closed Thursday’s trading session at $0.0004, up 33.3333%, on 284,169,938 volume. The average volume for the last 3 months is 284.17M and the stock's 52-week low/high is $0.0002/$0.0069.

Datasea (DTSS)

StockMarketWatch, MarketClub Analysis, TradersPro, QualityStocks, TopPennyStockMovers, StockOnion, Profitable Trader Authority, PennyStockScholar, PennyStockProphet, Penny Pick Finders, OTCtipReporter and Buzz Stocks reported earlier on Datasea (DTSS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Datasea Inc. (NASDAQ: DTSS) is an early-stage firm that is focused on the provision of security and software solutions.

The firm has its headquarters in Beijing, the People’s Republic of China and was incorporated in 2014, on September 26th by Xing Zhong Sun, Fu Liu and Zhi Xin Liu. Prior to its name change in October 2015, the firm was known as Rose Rock Inc. It operates as part of the technology sector, under the software and tech services industry and serves consumers across the globe.

The company offers elevator risk warning solutions, network security audit, smart linkage precaution systems and smart security solutions mainly to newly founded operating entities, partner agents, scenic or tourist attractions, schools and public communities via its own sales teams.

The enterprise develops a trio of smart security products, including the public community security system, the scenic area security system and the safe campus security system. It also develops smart 3D security and big data security platforms, as well as an epidemic system and provides data integration, data analysis and media advertising services. This is in addition to offering and developing education-related technologies to build science education platforms, education cloud platforms, education management systems and campus networks, as well as other education systems utilized in learning institutions.

The company’s wholly-owned subsidiary recently entered into 6 purchase and distribution agreements to provide 5G MMCP to companies located in different parts of China. The move will facilitate the expansion of its distribution network, which will not only have a positive effect on the company’s revenue and growth but also on investments into the firm.

Datasea (DTSS), closed Thursday’s trading session at $1.54, up 20.3125%, on 660,618 volume. The average volume for the last 3 months is 660,618 and the stock's 52-week low/high is $1.22/$6.84.

Coretec Group (CRTG)

TaglichBrothers and StocksEarning reported earlier on Coretec Group (CRTG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Coretec Group Inc. (OTCQB: CRTG) is a technology-based solutions firm that is focused on the development, testing and provision of different technologies, service solutions and products for energy-related industries.

The firm has its headquarters in Ann Arbor, Michigan and was incorporated in 1995, on August 11th. It operates as part of the communications equipment manufacturing industry. The firm has two companies in its corporate family and serves consumers in the United States.

The company’s innovative technology is based on CHS (cyclohexasilane Si6H12), a high value silicon precursor and the development of CSpace; a 3D volumetric display. The company was formed as a result of a merger between Coretec Industries LLC and 3DIcon Corporation.

The enterprise’s product portfolio is comprised of CHS, a liquid which converts to polysilane when it’s exposed to UV irradiation and heat, followed by amorphous silicon and crystalline silicon. It also develops a patented glasses-free 3D static volumetric display known as CSpace, which has been designed to produce high-resolution true 3D images with full color from 3D datasets transformed from raw datasets or datasets that have been generated by imaging systems, which can benefit from 3D visualization. The enterprise serves the international technology markets in security, environment, health, solar, semiconductor, electronics and energy.

The firm recently entered into an agreement with Richman Chemical Inc. which involves supplying its CHS to consumers in North America. This collaboration may have a positive effect on the firm’s growth and bring in more opportunities for expansion and investment.

Coretec Group (CRTG), closed Thursday’s trading session at $0.05, up 8.5776%, on 5,500 volume. The average volume for the last 3 months is 5,500 and the stock's 52-week low/high is $0.0425/$0.51.

BrainChip Holdings (BRCHF)

We reported earlier on BrainChip Holdings (BRCHF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BrainChip Holdings Ltd (OTCQX: BRCHF) (ASX: BRN) (FRA: 24Y) is a holding firm that is focused on the development of hardware and software accelerated solutions for machine learning and artificial intelligence applications.

The firm has its headquarters in Sydney, Australia and was incorporated in 2011. It serves consumers in Asia, the Middle East, Europe and North America.

The company is focused on developing advanced neural networking processors which bring AI to the edge in a way that current technologies aren’t capable of. Its neural network processor is based on the human brain’s spiking nature. The company is party to a research collaboration agreement with Biotome Pty Ltd, which entails SARS-CoV-2 antibody detection research.

The enterprise’s products include a machine learning framework known as Akida Development Environment for the creation, training and testing neural networks, as well as support the development of systems for edge AI on its event domain neural processor. It also offers an integrated solution for Edge AI devices and systems dubbed Akida Neuromorphic System-on-Chip; and Akida Neuromorphic Processor which offers a fast AI Edge network and ultra-low power for olfactory, audio, vision and smart transducer applications. The enterprise’s products are used in different applications, including cybersecurity and automotive uses.

The company recently partnered with MegaChips, a Japan-based global fabless semiconductor firm. This partnership will allow both companies to produce cutting-edge products while enabling BrainChip to grow and enhance its technology positioning for next-generation AI solutions. In addition to boosting the company’s growth, this move will encourage more investments into the company.

BrainChip Holdings (BRCHF), closed Thursday’s trading session at $0.5189, off by 0.211538%, on 70,216 volume. The average volume for the last 3 months is 70,216 and the stock's 52-week low/high is $0.23/$0.655.

Acceleware Ltd (ACWRF)

We reported earlier on Acceleware Ltd (ACWRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Acceleware Ltd (OTC: ACWRF) (CVE: AXE) is a gas and oil technology firm that is engaged in the development of oil and gas technologies.

The firm has its headquarters in Calgary, Canada and was incorporated in 2004. It serves consumers around the globe, with a focus on the United States and Canada.

The company operates through the High-Performance Computing and the RF Heating segments. The former segment is involved in the sale of computing software and related training programs and consulting services, mainly to the gas and oil industry. On the other hand, the later segment is focused on research, development and commercialization activities.

The enterprise develops technologies in two business units, i.e. seismic imaging software and radio frequency enhanced oil recovery. Its solutions include a modular full waveform inversion application known as AxFWI, which offers subsurface velocity models; a solution dubbed AxWAVE, which enables consumers to perform data characterization and model seismic acquisition; and a graphics processing unit known as AxRTM, which operates as a Kirchhoff time migration solution. This is in addition to offering an electromagnetic modeling software dubbed AxFDTD, which measures RF energy absorption; and a thermal enhanced oil recovery technology known as RF XL, for oil and oil sands.

The firm is advancing the development of its patented RF heating technology. Its current object is to position its RF heating technology in a prominent way in the clean-tech, gas and oil communities while driving external awareness of the firm. This will help boost investments into the firm while also driving its growth.

Acceleware Ltd (ACWRF), closed Thursday’s trading session at $0.4364, off by 7.0698%, on 11,000 volume. The average volume for the last 3 months is 11,000 and the stock's 52-week low/high is $0.0003/$0.5757.


We reported earlier on AAP Inc. (AAPJ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

AAP Inc. (OTC: AAPJ) is engaged in the provision of power, comfort and control systems for trailers, specialty vehicles, trucks, motor coaches and other applications.

The firm has its headquarters in Milford, Virginia and was incorporated in 1929 by Arthur Taubman. Prior to its name change in September 2011, the firm was known as Borneo Energy USA Inc. It operates as part of the motor vehicle and motor vehicle parts and supplies merchant wholesalers’ industry. The firm has three companies in its corporate family and serves consumers around the globe.

The company’sobjective is to create an organization which services and markets high tech products for demanding industries. It operates through the Independents and Worldpac, Carquest Canada, Southern Division and Northern Division segments.

The enterprise’s products include power transfer switches, electrical start assist devices, DC electrical systems, automatic computerized voltage disconnect systems, coolers, icemakers, freezers/refrigerators, sound attenuating foams, air purifiers, battery chargers and inverters, HVAC accessories and air conditioning/heating systems. It serves the special purpose vehicle, luxury motor coach, trucking, recreational vehicle, race car transporter, rescue, fire, medical and communication industries. The enterprise offers its products under the Vitrifrigo America, Domestic and AAP Inc. brands.

The company recently entered into a partnership agreement with North Star Developers LLC. This move enhances the company’s prospects for achieving its goals and adds to the company’s diverse and growing portfolio of businesses as well as its financial strength. The company is focused on solid business opportunities with attractive growth potential.

AAP Inc. (AAPJ), closed Thursday’s trading session at $0.023, even for the day. The average volume for the last 3 months is 4 and the stock's 52-week low/high is $0.0221/$0.25.

Winning Brands Corporation (WNBD)

OTCPicks, Stockpalooza, Penny Stock Finder, Stocks To Watch, MarketWireStocks, FOX Penny Stocks, Penny Stock Pick Report, fusionspicks, Hot Shot Stocks, Joe Penny Stocks, OTCReporter, Penny Champions, Penny Dreamers, Penny Invest, Penny Stock Pick Alert, Winning Penny Stock Picks, PennyPickAlerts, RisingPennyStocks, Stock Stars, Stock Traders Chat, StockEgg, Super Hot Penny Stocks, Super Nova Stock Picks, WePickPennyStocks and Penny Stock MoneyTrain reported earlier on Winning Brands Corporation (WNBD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Winning Brands Corporation (OTC: WNBD) is a manufacturing firm that is focused on the manufacture and sale of cleaning products.

The firm has its headquarters in Barrie, Canada and was incorporated in 1977. It serves consumers around the globe, with a focus on Canada and the United States.

The company manufactures independent cleaning product brands with an environmental focus. It mainly manufactures its products via Niagara Mist Marketing Ltd; its operating subsidiary, through third party contracting arrangements. The company’s extensive outsourcing has allowed it to gain flexibility and decrease its overhead costs.

The enterprise’s products include an all-purpose laundry cleaner dubbed the Laundry Miracle; a hard surface cleaner known as Clean1; a fire safety cleaner known as ReGuard4; and a stain remover, fabric softener and laundry detergent for families, dubbed Kind. It also develops a dirt surface performance enhancer known as TrackMoist, which is mainly used in outdoor and indoor sporting and entertainment venues; and a family of commercial garment cleaning and finishing agents used mainly for professional wet cleaning dubbed Brilliant; and a cleaning solution that removes stains from soft and hard surfaces, known as 1000+ Stain Remover. This is in addition to producing animal care and personal cleaning products. The enterprise’s lead retailer in Canada is Lowe’s Home Improvement stores.

The company is focused on expanding its scope through partnerships with various innovators as well as through new product ventures. This will be good for the company’s revenues and help bring in more investments into the company, which will have a positive effect on its growth.

Winning Brands Corporation (WNBD), closed Thursday’s trading session at $0.0009, off by 5.2632%, on 37,389,840 volume. The average volume for the last 3 months is 37.39M and the stock's 52-week low/high is $0.0003/$0.0062.

Q BioMed, Inc. (QBIO)

QualityStocks, MarketBeat, AwesomeStocks, StockRockandRoll, PennyStockLocks, SeeThruEquity Research, Penny Stock 101, Shiznit Stocks, Small Cap Firm, Stock News Now, StockPicksNYC, Penny Stock General, SmallCapVoice, Penny Stock 121, Penny Stock 115 and Journal Transcript reported earlier on Q BioMed, Inc. (QBIO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Q BioMed, Inc. is a biotechnology acceleration company listed on the OTCQB. It acquires, develops, and finances undervalued biomedical assets. The Company’s corporate vision is to create a pipeline of inventive biomedical assets in varied stages of development in manifold therapeutic areas. Its Food and Drug Administration (FDA) approved, non-opioid drug is Metastron. Q BioMed has its head office in New York City.

Q BioMed’s Metastron relieves cancer bone pain. It is approved for sale in 21 other countries. Further to treating pain, Metastron has shown evidence of treating the cancer itself and extending survival. Q BioMed’s plan is to conduct Phase IV trials to support label extension and cancer survival benefit using Metastron.

Additionally, the Company has its Uttroside-B. Uttroside-B is up to 10 times more potent against liver cancer cells than Sorafenib (preclinical data), the only FDA approved drug for first line treatment of liver cancer. Furthermore, Q BioMed has its QBM-001 for Pediatric Non-Verbal Disorder in dire need of treatment. The Company also has its Man-01 to treat glaucoma. Man-01 has shown to normalize Intraocular Eye Pressure (IOP) that is present in glaucoma patients. The Mannin platform has several potential drugs for treating vascular disease.

In February 2020, Q BioMed announced the launch of its FDA approved non-opioid drug Strontium89 (Strontium Chloride Sr-89 Injection, USP). This drug has been shown in clinical studies to help relieve persistent pain associated with cancer that has metastasized to bone. Q BioMed plans to launch Strontium89 in international markets, including Europe, in the coming quarters. Moreover, the Company is planning more research for Strontium89 for potential label extension into therapeutic use for survival benefit in metastatic bone cancer via a Phase IV study.

Q BioMed and Chemveda Life Sciences are continuing their collaboration on Uttroside-B, a chemotherapeutic that has shown notable potential efficacy as a treatment for liver cancer. While centered on its commercial rollout of Strontium89, this drug development program will advance another important asset in Q BioMed’s portfolio towards monetization. The efficacy of Uttroside-B, a potent saponin, against liver cancer was demonstrated in a preclinical study published in the November 2016 issue of Scientific Reports, a Nature journal.

Q BioMed, Inc. (QBIO), closed Thursday’s trading session at $0.5, up 44.9275%, on 953,973 volume. The average volume for the last 3 months is 948,765 and the stock's 52-week low/high is $0.265/$1.59.

Charles Schwab Corporation (SCHW)

MarketClub Analysis, The Street, StocksEarning, InvestorPlace, MarketBeat, Schaeffer's, Kiplinger Today, Louis Navellier, Market Report, StreetInsider, Daily Trade Alert, Daily Wealth, Trades Of The Day, Zacks, SmarTrend Newsletters, StreetAuthority Daily, Barchart, The Wealth Report,, Top Pros' Top Picks, Trading Markets, MarketWatch, Uncommon Wisdom, Investopedia, Money Morning, Profit Confidential, Power Profit Trades, Market Intelligence Center Alert, Cabot Wealth, StreetAlerts, Market Intelligence Center, Insider Wealth Alert, GorillaTrades, The Street Report, Dividend Opportunities, Wealth Insider Alert, Daily Markets, The Online Investor, Stockhouse, TopStockAnalysts, ProfitableTrading, The Growth Stock Wire, TradingMarkets, Trading Tips, Trading Concepts, Investor Guide, BestOtc, Investment U, CNBC Breaking News, Coattail Investor, FNNO Newsletters, Investing Futures, CRWEPicks, Inside Trading, Penny Stock Buzz, DrStockPick, Investiv, Stock Gumshoe, Wyatt Investment Research, Wealth Daily, TraderInsight, The Weekly Options Trader, The Tycoon Report, The Motley Fool, The Best Newsletters, The 10-Minute Millionaire, Street Insider, Navellier Growth, StockEarnings, InvestorGuide, SmallCapNetwork, PennyOmega, Penny Sleuth, 24/7 Trader, Momentum Trades, MarketClub, Market FN, InvestorsObserver Team, Investors Alley and StockMarketWatch reported earlier on Charles Schwab Corporation (SCHW), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Shares of Charles Schwab Corporation (The) (NYSE:SCHW) traded at a new 52-week high today of $85.75. This new high was reached on approximately average trading volume as 3.6 million shares traded hands, while the average 30-day volume is approximately 5.1 million shares.

Charles Schwab operates in the brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices and a well-established online investing website. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $6.5 trillion of client assets at the end of 2020. Nearly all of its revenue is from the United States.

Charles Schwab Corporation (The) (NYSE:SCHW) is currently priced 23.3% above its average consensus analyst price target of $65.51.

Over the past year, Charles Schwab Corporation (The) has traded in a range of $50.02 to $85.75 and is now at $85.39, 71% above that low.

Charles Schwab Corporation (SCHW), closed Thursday’s trading session at $83.89, up 2.8064%, on 9,825,122 volume. The average volume for the last 3 months is 9.507M and the stock's 52-week low/high is $50.61/$85.75.

The QualityStocks Company Corner

AmpliTech Group Inc. (NASDAQ: AMPG)

The QualityStocks Daily Newsletter would like to spotlight AmpliTech Group Inc. (AMPG).

AmpliTech Group (NASDAQ: AMPG), a designer, developer and manufacturer of state-of-the-art, signal-processing components for satellite and 5G communications networks, defense, space and other commercial applications, has completed the purchase of the assets and operations of Spectrum Semiconductor Materials Inc. Based in California, Spectrum is a rapidly growing global specialty distributor of semiconductor components. According to AMPG, the transaction should provide significant financial benefits to the company while also adding significant distribution reach. The announcement noted that Spectrum is on track to reach unaudited 2021 revenue $13 million unaudited revenue for 2021. The announcement also observed that Spectrum has an existing powerful distribution platform across the United States, Europe and Asia, which is ideal for AmpliTech’s new line of monolithic, microwave-integrated circuit (“MMIC”) chip designs. “Through the Spectrum acquisition we have substantially increased our revenue base with a well-managed, growing business known for high quality and excellent customer service,” said AmpliTech CEO Fawad Maqbool in the press release. “We expect the transaction will be immediately accretive to our top-and bottom-line financial performance. Spectrum also provides an ideal distribution platform to support the launch and commercialization of our MMIC chip solutions in core end markets of aerospace, defense, automotive and computing. We expect AmpliTech and Spectrum to play a key role in improving the speed and efficiency of 5G cellular networks and medium earth orbit and low earth orbit satellite communications systems around the world.” To view the full press release, visit

AmpliTech Group Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW) designs, develops and manufactures custom radio frequency (RF) components for the commercial, SATCOM, space and military markets. In addition to developing new products for the 5G/6G wireless ecosystem and infrastructure, the company has placed focus on the development of leading-edge solutions in quantum computing in support of U.S. efforts to reach the coveted position of quantum supremacy. The company maintains a commitment to R&D that allows it to remain at the forefront of emerging technologies. AmpliTech aims to use its advanced techniques and IP to provide tomorrow’s technology today, improving everyone’s quality of life.

AmpliTech was founded by Fawad Maqbool in 2002 to fill the need for affordable, high-quality, customized and state-of-the-art amplifiers and components. Headquartered in Bohemia, New York, the company currently has distributors and representatives available worldwide.

Product Portfolio

AmpliTech’s mission is to develop quality, state-of-the-art microwave amplifiers by leveraging its experience, proven technical expertise and superior design heritage. The company’s products cover a frequency range from 50 kHz to 44 GHz, with plans to eventually offer designs up to 100 GHz. Its current catalog includes:


Passive Components

All the company’s products come with a satisfaction guarantee, as the company is fully committed to providing only high-quality products free from manufacturing and material defects and guaranteed to perform according to applicable specifications.

Consulting Services

Leveraging more than 100 years of combined experience in microwave systems and component design ranging from active components to passive devices, AmpliTech also provides valuable consulting services and technical assistance to its customers.

With capabilities ranging from initial design to final manufacturing and delivery, the company’s team also offers project management services and advice on both technical aspects and how to handle business issues such as resource allocation, customer contact, budget restraints, time limits and more.

Other key benefits of AmpliTech consulting services that can give its customers a definitive edge include:

  • Timely technical assistance
  • Little or no learning curve
  • Less long-term costs associated with full-time employees with benefits and salaries
  • Availability when necessary
  • Customer support with schedules, project management and on the job training
  • Access to technology
  • Partnering for manufacturing and/or complete turn-key product solution
  • Personal guidance from concept to development
  • Custom designs for each application

Market Outlook

The global microwave devices market was valued at $7.44 billion in 2019 and is expected to grow at a CAGR of 3.23% and reach $9 billion by 2025 ( Governmental expenditures in the defense and space communications sectors are expected to expand the opportunities for growth within the industry.

AmpliTech continues to follow its strategy of identifying key elements in today’s technological revolution. It is leveraging its technical expertise and experience to align product portfolios and IP with innovation ( The company has plans to be a catalyst in the enhancement, development and distribution of breakthroughs in the following sizeable markets:

  • High Speed Terrestrial and Satellite Terminals (SATCOM, “Internet in the Sky”)
  • 5G/Wi-Fi6E and 6G wireless infrastructure (Cellular Base Stations, Small Cells, Private Wi-Fi Networks)
  • IoT (Internet of Things)
  • Cloud Farms, Big Data and MEC architecture
  • Quantum Supercomputers/Quantum Research
  • Deep Space Astronomy
  • Autonomous Self-Driving Vehicles
  • Telemedicine, AR/VR (Augmented and Virtual Reality)
  • Drones, UAVs (Unmanned Aerial Vehicles)
  • Cyber-security
  • Military/Defense ECM/EW

Management Team

Fawad Maqbool is the Founder, President, CEO and CTO of AmpliTech Group Inc. He has been in the microwave industry for over 30 years. Mr. Maqbool spent 14 years developing state-of-the-art amplifiers and components for MITEQ Inc., a leading microwave and communications equipment supplier. He founded AmpliComm in 2000, which was subsequently acquired by Aeroflex Inc. Mr. Maqbool has management and design experience, which has led to the development of microwave technology on a commercial and military level. He holds a B.S.E.E in Microwave Engineering and a B.S.E.E in Bio-Medical Engineering from CUNY and an M.S.E.E from the Polytechnic University of New York.

Louisa Sanfratello is the company’s CFO. She is a Certified Public Accountant (CPA) and has worked in various industries since 1998. During this time, she held roles as an accountant for charities and schools, consisting of the preparation of official financial documents and day-to-day financial management requirements. Ms. Sanfratello began her professional career in 1987 at Holtz, Rubinstein & Co., a public accounting firm. She gathered two years of experience there before gaining her CPA and taking on more challenging roles.

Brandon Worster is the company’s Director of Engineering. He joined AmpliTech at the end of 2019, bringing over 14 years of design and management experience. His specialty is Low Noise and Medium Power Amplifiers, but Mr. Worster also has vast experience with various systems, including RF/Microwave devices and systems. He holds a master’s degree in electrical engineering and is an adjunct professor at Farmingdale University in New York.

John P. Pastore is AmpliTech’s Director of Sales. He has worked in the microwave industry for more than 35 years, including time with some of the industry’s leading names. Mr. Pastore is a hands-on professional who has experience that spans over 20 years with progressive roles that blend technical, manufacturing, customer service and management expertise. He is an extremely valuable asset to the company as it moves forward due to his business savvy approach and deep industry knowledge. He has a B.S. in Business Management.

M. Syed handles Technical Sales and is the company’s Director of IT. He is an electrical engineer with more than 10 years of business experience. Since 2011, he has led Technical Sales for AmpliTech, and he recently became the President and CEO of his own company while also serving as Chief Technical Sales consultant for numerous other companies and groups in New York City. Mr. Syed has been in the IT industry for 25 years. He is a Computer Engineer by trade and a Certified Netware Engineer and Microsoft Certified Systems Engineer.

AmpliTech Group Inc. (AMPG), closed Thursday’s trading session at $3.54, up 0.283286%, on 1,274,505 volume. The average volume for the last 3 months is 1.275M and the stock's 52-week low/high is $2.60/$19.80.

Recent News

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF)

The QualityStocks Daily Newsletter would like to spotlight Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF).

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, today announced that the company and its digital therapeutics technology, iSTRYM, have been certified as Health Insurance Portability and Accountability Act (“HIPAA”) compliant. HIPAA compliance certification reflects MINDCURE's commitment to achieving the highest standards of medical data protection and privacy and is the next step in working towards having the iSTRYM technology platform classified a “Software as a Medical Device” by the FDA. “Receiving HIPAA compliance is a significant milestone for MINDCURE, which supports our goal of commercially deploying iSTRYM in the second quarter of 2022, as well as generating near-term revenue from the platform,” said Kelsey Ramsden, president and CEO of MINDCURE. “We developed iSTRYM as a drug-agnostic tool that we will be able to scale beyond psychedelics and into other therapeutic fields, which could result in additional revenue opportunities for MINDCURE in the future.” To view the full press release, visit

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (“MINDCURE”) is a diversified life sciences company at the forefront of the mental health industry. The company is currently developing digital therapeutics and researching psychedelic compounds, while innovating and commercializing new ways to promote healing and improve mental health.

MINDCURE’s research and digital therapeutics technology supports access to safe, science-based, evidence-backed psychedelic-assisted therapies globally. With hundreds of millions of people suffering from mental illnesses worldwide and an estimated $1 trillion in lost productivity per year, psychedelics offer promising alternatives for healing. This medical need has been amplified by the COVID-19 pandemic. According to the Centers for Disease Control and Prevention, 40 percent of U.S. adults reported struggling with substance abuse or mental health issues during the pandemic.

MINDCURE is uniquely positioned to address these medical needs. By concentrating on both technology and research, the company is focusing on near-term revenue generation, targeting a longer-term, blue sky horizon and hedging against regulatory unknowns with a scalable, adaptive model. MINDCURE’s software-as-a-service (SaaS) platform, iSTRYM, scales globally and services every psychedelic medicine without the capital-intensive drag of clinic scale-out costs. The company plans to first enter the market for psychedelic-assisted psychotherapy, then to move into the larger fields of technologically undisrupted psychotherapy and psychiatry.


Digital therapeutics include health interventions delivered through a smart device to induce a behavioral change in the patient. The global market is focused on simplifying behavioral change and empowering consumers to take charge of their own health. iSTRYM is the company’s AI-driven software platform that enables personalized and quantified outcomes in psychedelic therapy. The SaaS platform modernizes care, taking it from manual to digital and bringing better treatment outcomes for patients and therapists while lowering costs for insurers.

iSTRYM offers clinicians direct access to global, science-backed, evidence-based protocols, integration plans, insights into client journeys, and real-time assessments for personalized care. Patients access the platform on their smart devices, enjoying transparency into their wellness journeys, personalized care resources, and optimized relationships with their practitioners. The minimal viable product (MVP) of the software is being launched in Q3 2021. MINDCURE targets a Q1-Q2 2022 commercial product launch.


In June 2021, the company announced it had completed the first stage of manufacturing pharmaceutical-grade synthetic ibogaine to be used in clinical research. In July, MINDCURE announced it had filed U.S. Provisional Patent applications for the company’s first full synthetic routes to create ibogaine. The company’s pharmaceutical grade ibogaine would provide researchers access to a sustainable, high-quality, reliable, and consistent supply of the psychedelic drug.

The company is also actively researching ibogaine as a potential treatment for Traumatic Brain Injury and related conditions. Preliminary data show the drug may also have promise as a treatment for neuropathic pain and migraines. In addition, research indicates ibogaine may help repair and rewire the brain’s neural pathways, making it potentially useful in the treatment of addictions.

Market Outlook

MINDCURE actively develops technology, conducts research, and distributes products in several market spaces. The global market for digital therapeutics is projected to grow to $6.9 billion by 2025, from an estimated $2.1 billion in 2020. In North American alone, the market is forecast to reach $5 billion by 2025.

The market for treatment of drug, alcohol and other addictions is estimated to be worth $38.2 billion in 2021, with a forecast CAGR of 5.2 percent for the next several years. The global market for the treatment of neuropathic pain is forecast to account for $9 billion by 2027, while drug treatment for migraines is expected to have a value of $2.1 billion by 2025.

Management Team

Kelsey Ramsden is President and CEO of MINDCURE. She has 15 years of experience founding, scaling, and operating innovative companies across Canada and the Caribbean. She has built multiple eight-figure businesses and twice been named Canada’s Top Female Entrepreneur. She holds a seat on the Entrepreneurship Council for the University of Western Ontario, where she is also a faculty member. She has an MBA from the Richard Ivey School of Business at the University of Western Ontario.

Dr. Joel Raskin is the Chief Medical Officer at MINDCURE. He is a psychiatrist and academic with 20 years international pharmaceutical experience in neuroscience drug development, lifecycle preparation, launch and commercialization with Eli Lilly & Co., where, as Senior Director, he led the medical affairs team for Alzheimer’s disease diagnostics and therapeutics. He earned his medical degree from the University of Toronto and is a Fellow of the Royal College of Physicians and Surgeons of Canada in Psychiatry.

Tarik Lebbadi is the COO at MINDCURE. He has more than 13 years of international operational experience. Before joining the company, he led the medical division of Johnson & Johnson in Morocco. He holds a BA in mathematics and computer science from Ripon College and an MBA from IESE Business School in Barcelona, Spain.

Geoff Belair is the CTO at MINDCURE. He has 30 years of experience working in highly regulated industries, including fintech and banking. He was the senior architect and creator of the Integration Services Team at banking solutions company Fincentric Corporation. Before joining MINDCURE he was Vice President of Information Technology at Westland Insurance.

Michael Wolfe, CPA CA, is MINDCURE’s CFO. He has 30 years of experience in finance, accounting, private equity, and business valuation. He was previously CFO of Baylin Technologies Inc., as well as CFO of several mid-market Canadian companies, including Masstech Group Inc. He was General Partner at VenGrowth Capital Partners Inc. He holds an MBA from McMaster University and a BA in business and economics from the University of Western Ontario.

Daniel Herrera is Vice President of Growth & Strategic Partnerships at MINDCURE. He is a former pharmaceutical executive with extensive experience in highly regulated industries. He is experienced with medical affairs, product development and product licensing, negotiations with public and private payers, GPOs, and pharmacy buyers, as well as strategic partnerships resulting in high-value M&A transactions. He is a graduate of McGill University and the University of Montreal and holds an MBA from the John Molson School of Business at Concordia University.

Mind Cure Health Inc. (OTCQX: MCURF), closed Thursday’s trading session at $0.18083, up 12.2471%, on 282,925 volume. The average volume for the last 3 months is 243,647 and the stock's 52-week low/high is $0.151/$0.7326.

Recent News

DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF)

The QualityStocks Daily Newsletter would like to spotlight DigiMax Global Inc. (CSE: DIGI) (OTCQB: DBKSF).

  • DigiMax partners with BearClaw Esports to provide mutually beneficial collaboration
  • Bitget partnership gives Cryptohawk users great opportunity to increase the efficiency and security of their trades
  • DIGI join forces with prominent leader in the crypto industry in Asia

Powerful partnerships are key to a company’s success, and over the past six months, DigiMax Global (CSE: DIGI) (OTC: DBKSF) has built a portfolio of powerful partnerships, all designed to support the company’s strategic global efforts to unlock the potential of disruptive technologies by providing advanced financial, predictive and cryptocurrency solutions across various verticals.

DigiMax Global Inc. (CSE: DIGI) (OTCQB: DBKSF) is an artificial intelligence technology and services company producing and leveraging predictive indicators across various industries and verticals.

The company offers financial, business, and human capital AI predictive solutions to businesses, institutions, and consumers to improve decision-making.

The DigiMax core solutions are:

  1. CryptoHawk AI – CryptoHawk is a deep learning AI solution (SaaS) that monitors and analyzes live select cryptocurrencies and financial markets. The CryptoHawk AI solution is offered to retail clients as a monthly subscription. Generated data provides subscribers with price trend predictions for better investment strategies.
  2. Cryptocurrency Hedge Fund – A long/short cryptocurrency hedge fund for high net worth, institutional, and family office clients was launched on September 1, 2021. The company’s crypto hedge fund earns clients’ management and overall performance fees.
  3. Projected Personality Interpreter (PPI) – DigiMax solutions utilize AI to provide comparative insights for better hiring decisions, reduced employment attrition, improved workplace culture, and augmented human and financial predictive services by measuring and correlating personal attributes.
  4. Navee Predict – DigiMax data scientists provide companies with the unprecedented power of enhancing decision-making by analyzing, detecting changes and forecasting patterns.

The company’s team has extensive experience in finance, trading, machine learning (ML), neural language processing, AI, big data, and cryptocurrency technology. DigiMax leverages AI and its expert team to translate data into actionable predictive insights across the financial, business, and human dimensions, enhancing the decision-making capacity of organizations. DigiMax is an official IBM Watson partner with more than 30 years in data science and artificial intelligence.


Business and Financial Capital Solutions

CryptoHawk AI is a cryptocurrency price and trend prediction solution offered as a web application ( and a mobile application by the end of 2021. The value for the user is to capture gains and take advantage of volatility while reducing risk and engaging in smarter and simpler trading.

The key features:

  • Trend Prediction Indicator (“TPI”)
    The TPI is a superior model that leverages the cryptocurrencies analyzed by the AI and other market-driven data and policies to produce actionable predictions in the form of:
    • Prediction cards
    • Cryptocurrency graphs with optional market indicators
    • Email/SMS alerts
  • Trend Watch
    Trend Watch is a one-week look ahead machine learning prediction for a select portfolio of mature cryptocurrencies. Trend Watch predicts a trend being UP or DOWN and provides a price target. Users have access to:
    • A list of select cryptocurrencies with predictive graphs

The system alerts investors through email and text messages when a price trend changes, allowing users to act confidently.

Cryptocurrency Hedge Fund

On September 1, 2021, DigiMax launched its Cryptocurrency Hedge Fund to offer high net worth, institutional, and family office clients a fully systematic long/short active investment into a basket of cryptocurrencies capitalizing on crypto volatility and powered by proprietary trading algorithms. The official launch is expected in the coming months.

The fund is led by 40-year hedge fund veteran Ian Hamilton and has an experienced investment and fund management team. This actively managed fund provides an excellent opportunity for larger investors to gain exposure to cryptocurrencies.

AI Business Prediction as a Service

The company offers predictive insights to businesses through automation and its innovative and proprietary AI and ML technology. Traditional models are expensive, because they are created and developed by data scientists dedicated to solving specific business questions that require costly customization and weeks, if not months, of development. With DigiMax, companies have access to solutions and services at a fraction of the price of traditional and experimental approaches. By combining AI with ML prediction technology, the company delivers insights on:

  • Sales forecasts
  • Optimal inventory levels
  • Supply chain management
  • Invoice payment projections
  • Targeted segmentation for marketing campaigns

Human Capital Solutions

AI-Powered Projected Personality Interpreter

The Projected Personality Interpreter (“PPI”) evaluates and improves customers’ workforce, brand and culture by revealing the personality traits and sentiment buried in human expression. The PPI empowers organizations with comparative insight for better hiring decisions, reducing employment attrition and improving workplace culture.

PPI provides a comprehensive and complete solution, offering:

  • Recruitment campaign management
  • Custom questionnaires, desirable traits recipes, and group likenesses
  • Detailed personality reports to compare and contrast peers
  • API for advanced integration with alternative systems of record

DigiMax leverages IBM Watson and a custom algorithm that analyzes applicant responses across 52 different traits and compares those scores with a baseline, providing hiring managers with a comprehensive report that improves decision making and takes the bias out of the process. The company’s solution is currently in use by 17 law enforcement agencies in North America and is used across the 10 global recruitment brands of Shepherd Search Group.

Market Overview

The AI industry has a five-year CAGR of 18.4%, with revenues projected to reach $37.9 billion by 2024. Some more optimistic forecasts have the market worth as much as $15 trillion by 2030. It’s estimated that 80% of all emerging technologies in 2021 have AI foundations. About 40% of all businesses use AI in their operations. According to Industry Ark, artificial intelligence use in the recruitment market was valued at $580 million in 2019.

Management Team

Chris Carl, CEO

Chris Carl has over 20 years of experience as a public-company CEO and has built several successful businesses across multiple categories. He has a proven ability to lead and has a track record of execution, revenue growth, and value creation.

Thierry Hubert, CTO

Thierry Hubert has 30 years of technology experience with Fortune 100 companies worldwide and is an early pioneer in applying artificial intelligence to solve big data and unstructured information challenges with IBM as a Director of R&D in emerging technology, knowledge management, and process innovation. He has received awards, recognitions, and grants that contributed to his ongoing collaboration with industry leaders.

David Bhumgara, CFO

David Bhumgara is a senior finance executive with over 25 years of leadership experience and proven expertise in finance, financial reporting, accounting, corporate finance, budgeting, financial modeling, and mergers & acquisitions.

Damon Stone, Trading Strategy Advisor

Damon Stone is an experienced stock and crypto trader who works very closely with the data science team as a subject matter expert. During 15 years at Merrill Lynch as a market maker and proprietary trader, he traded many different sectors, culminating in heading up a $250 million trading desk.

Ross Power, Senior Innovation Engineer
Ross Power is an experienced technical system architect with a demonstrated history of working on advanced technologies, including AI algorithms, IoT solutions, 3D printing, Innovation in BCI (Brain-Computer Interfacing), and RC flight and navigation systems.

DigiMax Global Inc. (DBKSF), closed Thursday’s trading session at $0.0538, up 0.749064%, on 17,377 volume. The average volume for the last 3 months is 17,377 and the stock's 52-week low/high is $0.05/$0.70.

Recent News

Endexx Corp. (OTC: EDXC)

The QualityStocks Daily Newsletter would like to spotlight Endexx Corp. (EDXC).

Endexx (OTC: EDXC), a provider of innovative hemp-derived cannabidiol (“CBD”) wellness and health products, today announced that it has surpassed its current store count goal after adding 2,800 stores in the month of December. As previously announced, Endexx recently expanded into 1,000 stores of a major food/drug/mass (“FDM”) retailer chain, continuing an upward trend to place its product line in stores nationwide. Now in 44 states, Endexx aims to expand its products to 20,000 stores, which management believes is a realistic goal and well within the company’s reach to achieve by the end of 2022. Endexx is dedicated to quality and features products with targeted delivery, controlled dosing, functional plant-based ingredients and advanced formulas. To view the full press release, visit

Endexx Corp. (OTC: EDXC) is a leading producer and manufacturer of hemp-derived cannabidiol (CBD) wellness products and a provider of innovative phytonutrient-based nutritional products. Through its operating division, CBD Unlimited Inc., Endexx develops and distributes all-natural CBD products derived from the cannabis sativa-L plant, often referred to as the hemp plant, containing less than 0.03% THC, the psychoactive compound in cannabis.

Under its four major brands – CBD Unlimited, Phyto-Bites, Maggie’s and BLESSWELL – the company’s products range from oils, capsules and topicals to pet products, all with the shared purpose of therapeutic effect and pain relief for humans and pets.

Endexx incorporates science and compliance as the foundation for the development of all its products. Because the company utilizes high quality functional ingredients to formulate its products, most customers have positive experiences which outperform their expectations. This differentiates the Endexx line of products in the market.

CBD Unlimited™

CBD Unlimited™, a subsidiary of Endexx, was founded in 2014 with the belief that CBD unlocked a new frontier in healing. Since its founding, CBD Unlimited has been a premier developer of hemp-derived products, each formulated to address key segments of the health and wellness market.
CBD Unlimited’s mission is to deepen and share understanding regarding the state of the science of cannabinoids. Through its e-commerce site, the subsidiary sells high-end CBD oils, topicals, capsules, snacks and beverages.

On November 4, 2021, Endexx announced plans for a “near-future” nationwide specialty and convenience store roll-out of the CBD Unlimited Value Line of products, with an aim of aggressively expanding its retail footprint through a major distribution partner.


On May 21, 2021, Endexx announced that it had joined forces with music mogul, business guru and GRAMMY® Award-winning artist DJ Khaled to create a master barber-approved, top shelf line of CBD-enhanced grooming products – BLESSWELL™.

As noted in the press release, the sustainably sourced collection features 100% U.S. grown and processed hemp products that focus on a more natural approach to achieving the healthiest hair and skin. BLESSWELL was created to introduce men to a whole body, holistic form of self-care, which was inspired by DJ Khaled’s pursuit for wellness and time spent in the “Honeywell of the Jamaican Irie”.

“Aside from love and family, health and wellness are our greatest blessings. That’s the key,” DJ Khaled stated in the press release. “Reflecting on my quest to a better mind and body, I found my daily habits to have the most impact on my overall outlook of life. I created BLESSWELL to provide men with an at-home CBD grooming solution that allows them to put their game face on, build their confidence and get their mind in the right zone.”

Recently, BLESSWELL has been receiving high praise and mass exposure as many celebrity influencers have mentioned the product on their social media. In addition, a large-scale, BLESSWELL pop-up store was successfully launched in Chicago.

On November 4, 2021, Endexx announced that it had received a vendor number and had cleared compliance with “a major well-known drug chain” for the placement of the BLESSWELL product line. The initial agreement will target approximately 1,000 stores in North America. The release further notes, “This launch into 1,000 major retail stores signifies that Endexx will achieve its readjusted store-count goal of 5,000 stores in 2021, in FDM (Food/Drug/Mass) retail post the COVID-19 pandemic.”

Other Brands & Initiatives

  • Phyto-Bites, the company’s pet product line, includes CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The science behind the company’s products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving.
  • Maggie’s Line features scientifically formulated, soothing mists and balms that deliver the signature relaxation of CBD, paired with the power of Arnica and MSM with the tantalizing scent of lemongrass.
  • Ocho Rios Herb House was recently soft-launched by Endexx’s Go Green Global subsidiary. The storefront, located in the Taj Mahal shopping center in Ocho Rios, Jamaica, will carry premium marijuana and other related premium products for consumers. Ocho Rios is the largest port on the island and received about 40% of overall visitors in Jamaica in 2019.

Market Outlook

According to a report from Grand View Research, the global CBD market was valued at $2.8 billion in 2020 and is expected to expand at a CAGR of 21.2% from 2021 to 2028. That would put the market value at more than $13 billion by the end of the forecast period.

Due to the healing properties of CBD, the demand for health and wellness products containing CBD is expected to rebound from a COVID-19-caused slowdown and remain high. Grand View identifies this demand as the major factor driving market growth. In addition, the rising acceptance and use of CBD products due to government approvals is a major factor expected to boost the market.

The Grand View report states that increasing awareness of CBD’s therapeutic benefits has influenced buyers to purchase cannabidiol products, regardless of cost. Because CBD products typically have a greater profit margin, commercial retailers are now ramping up their focus on selling hemp- and cannabis-based products. A number of the largest U.S. retailers now stock CBD products on their shelves.

Management Team

The Endexx management team and its advisory group each have between 10 and 50 years of experience in their respective fields. These professionals all have experience in growing businesses, as well as in developing and implementing new consumer products and technologies with an emphasis in the medical, biotech and life science industries.

Endexx Corp. (EDXC), closed Thursday’s trading session at $0.043, up 1.8957%, on 885,980 volume. The average volume for the last 3 months is 885,980 and the stock's 52-week low/high is $0.0406/$0.2849.

Recent News

Marijuana Company of America Inc. (OTC: MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

  • MCOA just posted its highest quarterly revenue yet in Q3 2021, attributed to the cDistro acquisition, which was completed towards the end of Q2 2021
  • MCOA looks forward to having another record-breaking quarter in Q4, 2021, primarily attributed to additional benefits of the cDistro acquisition, along with strategic partnerships with key players within the legal cannabis and industrial hemp sectors
  • The company continues to forge these partnerships to diversify its product and services line and provide consistent value to its shareholders

Marijuana Company of America (OTC: MCOA) released financial results for the three months ended September 30, 2021 (“Q3 2021”), posting a 731% year-on-year increase from the same period in Q3 2020. Total revenue stood at $442,178 up from $53,195, with gross profit up from $16,025 in Q3 2020 to $63,687, representing a 297% growth over that period ( 

Marijuana Company of America Inc. (OTC: MCOA) operates and invests in the cannabis sector directly. The company’s diverse operations include cDistro, one of the THC, hemp & CBD cannabis industries’ fastest growing distribution companies; hempsmart™, a premium CBD company; and VBF Brands Inc., a cannabis nursery cultivation facility in Salinas, California, that is a cultivator and distributor utilizing its own growing systems to produce desirable cannabis clones.

MCOA continues to grow its business while remaining fiscally conscious and further establishing itself in the legalized cannabis THC, hemp & CBD industries by offering unique exposure to the global cannabidiol sector. The company intends to continue to leverage its premium brand hemp-based products with investments in and collaboration with existing and new strategic partners.

Marijuana Company of America offers investors the opportunity to be at the forefront of innovation in the legal cannabis and industrial hemp industries.
During the summer of 2021, the U.S. witnessed the introduction of the most comprehensive cannabis reform ever proposed at the federal level, as well as ongoing state-level liberalization. The investments MCOA has made will position the company to drive the expected strongest revenue growth in the company’s history.

MCOA strives to develop a comprehensive selection of synergistic companies that provides consistent value to its shareholders. Furthermore, its vertically integrated business model provides companies and partners with the best opportunities for rapid growth. It is MCOA’s attention to detail in producing premium products and adhering to the best business practices that distinguish it among the leaders of cannabis products in the global marketplace.

MCOA is building a portfolio of investments and joint ventures that represent the highest integrity and professionalism in the legal cannabis and industrial hemp markets. MCOA is a model for entrepreneurs and businesses that share its common goals and philosophies of not only creating value for investors but also creating an environment for businesses to improve the quality of life of customers through sustainable alternatives to many products currently on the market.

Partnerships and Investments

MCOA has partnered with and invested in a portfolio of companies operating in the cannabis sector. These include:

Cannabis Global Inc.

Cannabis Global Inc. (OTC: CBGL) is an emerging force in the cannabis marketplace with growing product and intellectual property portfolios. CBGL is marketing and producing Comply Bag™, an innovative solution for cannabis storage, transport, and tracking, and is also the developer and marketer of the Hemp You Can Feel™ brand.

Eco Innovation Group Inc.

Eco Innovation Group Inc. (OTC: ECOX) works with inventors and other professionals to nurture and catalyze the most innovative and impactful products and services and deliver those innovations to market. ECOX is dedicated to developing and commercializing successful products.

MCOA’s investment supports Eco Innovation’s cutting-edge extraction technology. ECOX’s extraction processes utilize a proprietary formulation to extract valuable bioactive compounds from cannabidiol (CBD) combined with plant-based materials to create a fluid and cost-effective output.

Together, both companies are positioned to identify and accelerate the development of new varieties of hemp-based products and distribute them worldwide.

Natural Plant Extract

MCOA owns a direct investment interest in Natural Plant Extract (NPE), which operates a licensed cannabis manufacturing and distribution business in Lynwood, California. NPE holds a Type 7 California manufacturing and distribution license, allowing for cannabis product distribution anywhere in the State of California.

Wholly Owned Subsidiaries


hempsmart™ is a CBD company focused on creating and promoting the most effective, best tasting, and highest quality products on the market.

In 2021, hempsmart expanded into the global marketplace and announced a rebrand that featured a fresh take on its packaging and a social media campaign to engage customers via Instagram, Twitter, TikTok, and more, which has now generated a new loyal group of followers.

hempsmart premier products include its Smart Drops (CBD Drops), Neuro Smart (Patented Brain Pills), and Smart Cream (Pain Cream) brands. These organic, plant-based products help to manage anxiety, pain and insomnia, without the inclusion of THC.


cDistro distributes CBD brands, along with smoke and vape shop-related products, to wholesalers, c-stores, specialty retailers, and consumers in North America.
cDistro was chosen as one of the first to distribute Marley One, the first global functional mushroom brand, in collaboration with the Bob Marley Family.
The initial product offering will include a range of functional mushroom tinctures, including species such as cordyceps, lion’s mane, chaga, reishi and turkey tail, that offer a range of unique health and wellness benefits, from immunity and gut health to cognitive function and sleep enhancement.

VBF Brands Inc.

MCOA recently completed the acquisition of VBF Brands Inc., a fully licensed marijuana cultivator and distributor based in Salinas, California. VBF utilizes its own growing systems to produce desirable cannabis clones that are designed to assist growers by reducing uncertainty and enhancing the likelihood of a successful cultivation harvest. Cannabis clones carry the exact same genetic potential as their mother plants and have similar cannabinoid and terpene profiles when grown properly.

This subsidiary will immediately work toward increasing production at its Salinas facility, which also offers exponential growth potential with other nearby properties that MCOA has an option to participate in as part of the acquisition.

Market Outlook

Ongoing changes in U.S. state government policies toward cannabis are expected to cause demand for legal marijuana to surge. In addition, the number of indications for which medical marijuana is prescribed continues to increase. These factors are expected to rapidly boost legal sales of cannabis products. Furthermore, an anticipated federal legalization of medical marijuana in the U.S. will increase opportunities for this market.

According to a Grand View Research report, the global legal marijuana market was valued at $9.1 billion in 2020. Market size is forecast to grow at a CAGR of 26.7 percent from 2021 to 2028. That would put the market value at roughly $30 billion by 2025.

The report cites the growing number of countries that are legalizing cannabis as a driver for surging demand. It also points out the use of medical marijuana for various ailments is gaining momentum worldwide. Medical marijuana is prescribed for patients suffering from chronic illnesses such as Parkinson’s, cancer, Alzheimer’s and other neurological disorders. The demand for cannabis oil is also increasing rapidly, especially among countries with legalized medical marijuana.

Management Team

Jesus Quintero is the CEO and Chairman of MCOA. From January 2013 to September 2014, he was the Chief Financial Officer of Brazil Interactive Media Inc. Since 2011, he has served as a financial consultant to several multimillion-dollar businesses in South Florida. He has extensive experience in public company reporting and SEC/SOX compliance and held senior finance positions with Avnet Inc., Latin Node Inc., Globetel Communications Corp., and Telefonica of Spain. His prior experience also includes positions at Price Waterhouse and Deloitte & Touche. He holds a B.S. in Accounting from St. John’s University and is a certified public accountant.

Marijuana Company of America Inc. (MCOA), closed Thursday’s trading session at $0.0015, even for the day, on 40,749,483 volume. The average volume for the last 3 months is 37.008M and the stock's 52-week low/high is $0.0013/$0.0398.

Recent News

FingerMotion Inc. (OTCQX: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (OTCQX: FNGR) .

  • FingerMotion currently targets over one billion users within the Chinese market
  • The company is a crucial player within the telecommunications and insurtech markets, which are projected to post CAGRs of 5% and 48% from 2020-2025 and 2021-2028, respectively
  • Progress is seen by the company’s move to form a collaborative alliance with Munich Re, through JiuGe, its wholly-owned subsidiary 

FingerMotion (OTCQX: FNGR) has defined itself as an evolving technology company that is constantly pushing boundaries in telecommunications, big data insights, and Rich Communication Services (“RCS”), among others. Its focus on the Chinese market has made it a force to be reckoned with, evidenced by its growing year-over-year revenue since its founding in 2016.

FingerMotion Inc. (OTCQX: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Thursday’s trading session at $5.4, off by 0.184843%, on 17,280 volume. The average volume for the last 3 months is 17,280 and the stock's 52-week low/high is $3.22/$17.00.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

Two new studies led by researchers from Yale have discovered new information about the ALK receptor (anaplastic lymphoma kinase molecule) and the role it plays in cancer formation. The studies have made progress in determining ALK’s structure status as a receptor protein. Their findings were published in “Nature.” The codirector of the Cancer Biology Institute, Joseph Schlessinger, is a senior author of one of the studies. Yale School of Medicine assistant professor of pharmacology Daryl Klein is the senior author of the second study. A postdoctoral associate in Klein’s laboratory, Tongqing Li, stated that ALK was one of the receptor tyrosine kinases whose activation led to carcinogenesis. ALK receptors are primarily located in the central nervous system and the brain. These two studies are likely to shed more light on brain cancers and how they develop, and such information would be a valuable addition to the work being done by various biotech companies such as CNS Pharmaceuticals Inc. (NASDAQ: CNSP) that are looking to commercialize more effective treatments for primary brain cancers.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Thursday’s trading session at $0.911, off by 1.0428%, on 368,178 volume. The average volume for the last 3 months is 368,157 and the stock's 52-week low/high is $0.89/$4.46.

Recent News

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF)

The QualityStocks Daily Newsletter would like to spotlight Red White & Bloom Brands Inc. (OTCQX: RWBYF).

The state-legal cannabis industry has come quite a long way, all things considered. After decades of racially motivated prohibition and the proliferation of anti-cannabis propaganda, Americans in dozens of states can now legally access the controversial plant. Dozens of states now allow medical marijuana while nearly 20 states have passed recreational cannabis legislation, building a massively lucrative state-legal cannabis market and attracting plenty of new businesses. Coincidentally, a lot of the talent drawn to America’s nascent cannabis industry is from the consumer packaged goods (“CPG”) space, and these experienced professionals are applying techniques they learned to the young but lucrative sector. As the industry grows over the coming years, we are likely to see a lot more innovation from sector players such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) as the fight to consolidate market dominance intensifies.

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) is a torchbearer blazing a new frontier in American cannabis by adhering to the highest ethical, manufacturing, educational, branding and employment standards available in the industry.

Red White & Bloom is a super state operator, leveraging a sizable footprint to dominate the areas in which it operates. CEO Brad Rogers and other management members have seen the struggles of multi-state operators who have spread themselves too thin, which is why Red White & Bloom is intent on dominating each state it enters before expanding further.

Although targeting individual states in the United States, the company is headquartered in Toronto, Canada. Red White & Bloom was established after privately held MichiCann Medical Inc. merged with publicly traded Tidal Royalty in 2019.


Red White & Bloom has entered strategic brand acquisitions and partnerships aimed at helping the company expand its presence and position as one of the largest players in the United States cannabis market. Red White & Bloom is always diligently searching for brands to acquire that will provide additional value to the company and expand its national footprint.

The company’s current brand portfolio includes:

  • Platinum Premium Cannabis Products (PV): Platinum uses innovative thinking, honesty and responsibility to remain at the forefront of the cannabis industry. PV holds itself and its partners to the highest standards, providing clean and safe CBD and THC products. In the company’s press release dated January 13, 2021, it reported system-wide sales of Platinum-branded products exceeding $2.8 million for the first week of January alone.
  • High Times®: In June 2020, the company acquired the licensing rights and branding of High Times dispensaries and High Times cannabis-based CBD and THC products in Michigan, Illinois and Florida. The company also acquired branding of High Times hemp derived CBD products nationally in the United States carrying the Culture® brand.
  • Mid-American Growers: Mid-American began as a family operation in 1971 in Granville, Illinois. The original 8-acre greenhouse has expanded to a 3.6-million-square-foot, state-of-the-art technology and science facility under glass. Mid-American’s product offerings include its CBD Icy Relief Salve, CBD Icy Relief Roll-on and CBD Gummies.

Retail Focus

Red White & Bloom is working to establish a significant retail presence across multiple jurisdictions. In Michigan, the company is invested in and has the rights to acquire (subject to regulatory approvals) a licensed operator that controls the assets of 18 dispensary locations throughout the state. Red White & Bloom is also pursuing opportunities in Florida aimed at making its proposed retail footprint compelling and attractive to the majority of cannabis consumers within each state.


Red White & Bloom is focused on standardization and quality, with everything guided by a relentless commitment to the highest standards. The company acquired a 3.6-million-square-foot standardized facility dedicated to helping it achieve premium value for the products it intends to cultivate.

As it continues to expand, the company remains committed to the practices that have guided its success in the past, including:

  • A top-down approach to cultivation developed under the guidance of PhDs with expertise in growing principles, SOPs and, most importantly, the science behind it all.
  • Commitment to exceeding the requirement of the states in which it operates. The company cut its teeth under the world’s first national cannabis purity regime – a regime that most new markets use as a benchmark – so quality is in its DNA.
  • Science-driven production methods supported by automated, perpetual, standardized operations that enable craft cannabis-like quality at an industrial scale.


Assuming completion of the currently proposed investments and acquisitions, Red White & Bloom will be among the cannabis market’s largest companies, joining the ranks of a select few multi-state operators dominating the industry. Red White & Bloom currently has assets (closed and in closing stages) in Michigan, Illinois, Florida, California, Oklahoma and Massachusetts.

The company’s strategic acquisition and super state operator model, combined with its commitment to top-quality product and service, position it to become a leading player in the North American cannabis market.

When evaluated beside competitors in the cannabis space, Red White & Bloom boasts an extremely attractive valuation. While large cap cannabis firms serving North American markets averaged enterprise-value-to-EBITDA multiples of 14.9x as of December 2020, Red White & Bloom’s enterprise multiple was just 3.4x, as noted in the company’s latest investor deck.

In 2020, the cannabis market worldwide was valued at $24.6 billion. This amount is expected to expand at a CAGR of 14.3% from 2021 to 2028, resulting in a market size of $84 billion in 2028 ( Of the 2020 valuation, the largest revenue share (91.1%) was attributed to North American consumers (

Management Team

Brad Rogers is the CEO and Executive Chair of Red White & Bloom. He is a visionary for the future of cannabis and CBD products in the United States market, with a proven track record of building successful and profitable businesses in the rapidly expanding and new economic sector. Mr. Rogers was a part of the team that built one of the first commercially scaled production facilities in the world for medicinal cannabis. He also served as President for one of the leading licensed producers in Canada. Both of his ventures were successful, with a combined market cap of $2 billion.

Michael Marchese is the company’s Co-Founder and Marketing Advisor. He has played a crucial role in its development and organization, overseeing capital raises, acquisition strategy and brand identity. Mr. Marchese has a strong reputation and presence in the cannabis industry. He also co-founded and directed the branding of Aleafia Health Inc., which he continues to counsel. Through his branded company, Marchese Design, he has served as a highly trusted counselor to top-level execs, including C-Suite level employees, offering insights into the process of creating, building and maintaining brand identities.

Theo van der Linde is the CFO and Director of Red White & Bloom. He is a Chartered Accountant with 20 years of experience in finance, administration and public accounting. The experience he has acquired spans multiple industries, including mining, oil & gas, financial services, retail and manufacturing. For the last nine years, he has primarily focused his career on the mining industry, working with junior exploration and producing mining companies at various stages of growth in several jurisdictions. Mr. van der Linde is also the current President of Executive Management Solutions Ltd.

Red White & Bloom Brands Inc. (RWBYF), closed Thursday’s trading session at $0.3294, off by 1.0662%, on 239,894 volume. The average volume for the last 3 months is 239,894 and the stock's 52-week low/high is $0.32/$1.65.

Recent News


The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

LQwD Fintech (TSX.V: LQWD) (OTCQB: LQWDF) recently launched a Lightning Network platform-as-a-service (“PaaS”) offering that allows users to send and receive payments instantly, securely and inexpensively worldwide. The platform supports the growth and usage of the Lightning Network by establishing payment channels across the network’s ecosystem. Dedicated to enabling easier access to the Lightning Network and driving bitcoin adoption through an enterprise-grade infrastructure, LQwD believes that the Lightning Network will be a force of global change and the premier monetary exchange network of the future. “Companies leveraging LQwD’s Lightning Network nodes will be able to monitor, deploy and manage these nodes with no-to-low levels of technical expertise,” reads a recent article, which also contains comments by LQwD Chief Technology Officer Albert Szmigielski. “The Lightning Network is an extremely dynamic new global monetary network that’s growing exponentially, and we’re excited to be a solutions provider in the space,” Szmigielski said. “Needless to say, we’re looking forward to becoming a major contributor to (and supporter of) bitcoin’s scaling layer — the Lightning Network.” To view the full article, visit

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.


The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

Market Outlook

Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

Management Team

Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

LQwD FinTech Corp. (LQWDF), closed Thursday’s trading session at $0.315208, off by 4.5836%, on 21,142 volume. The average volume for the last 3 months is 21,142 and the stock's 52-week low/high is $0.25/$4.00.

Recent News

Asia Broadband Inc. (OTC: AABB)

The QualityStocks Daily Newsletter would like to spotlight Asia Broadband Inc. (AABB).

A leading independent precious metals research consultancy expects silver to benefit from the rising price of gold early next year. The consultancy firm, Metals Focus, reported this in its recently released 2021/2022 annual report, which focuses on investment in silver, gold, palladium and platinum. Director of Silver and Gold at Metals Focus, Neil Meader, stated that the innate high volatility of silver meant that the metal could probably outperform gold during early 2022. However, the consultancy added that the metal’s prices would probably drop after this, especially when the Federal Reserve gives a more clear guidance on the timing of the first post-coronavirus interest rate increase. The firm believes that the favorable fundamentals of silver may, despite this, provide some price support in 2022. The future looks bright for precious metals companies such as Asia Broadband Inc. (OTC: AABB), which have a firm foot in the market for silver and other precious metals.

Asia Broadband Inc. (OTC: AABB) is a resource company focused on the production, supply and sale of precious and base metals, primarily to Asian markets.

The company utilizes its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Mexico to client sales networks in Asia. This vertically integrated approach to sales transactions differentiates Asia Broadband from its competitors in the mining space.

Development Program in Colima, Mexico

In October 2020, Asia Broadband announced its acquisition of a high potential mineral property in the state of Colima, Mexico. Per the press release, previous geophysics and groundwork have revealed strong indications of significant mineralization in multiple sectors of the property.

The company recently began the construction of exploration and development facilities and infrastructure roads on its Colima property, and plans are underway to extend previous geophysics and groundwork on the property. In January 2021, Asia Broadband announced its allocation of $10 million for the initial development program, with the aim of accelerating operations at the Colima site toward production.

Positioned in a major gold-iron-copper production area, the company’s Colima property is situated approximately 25 kilometers east of the Pena Colorada mine in Minatitlan, Mexico. It is advantageously located, with direct access to main Highway #3, and the property also has an essential natural water supply.

AABB Gold Token

In December 2020, Asia Broadband announced its entry into a definitive development agreement with Core State Holdings Corp., a digital assets and crypto wallet creator, to produce a white label gold-backed cryptocurrency coin. The AABB Gold token is an ERC-20 token being developed on the Ethereum blockchain.

In a February 2021 news release, the company provided a development update on the cryptocurrency token, noting that Core State Holdings Corp. “is continuing to modify the set-up and move through the final stages of testing of the iOS and Android AABB Wallet applications, including the implementation of an application interface to allow users to see the real-time exchange rate of gold that backs the price of the AABB Gold token set at one-tenth of a gram or approximately $5.80 USD.”

Core State Holdings Corp. has also continued to enhance, which the company notes will be the go-to knowledge base for all information concerning the soon-to-be launched AABB Wallet and AABB Gold token.

AABB’s primary goal for the token is to become a worldwide standard of exchange – secured and trusted with gold backing – by expanding circulation and targeting large population and high growth markets globally, including China and East Asia.

Asia Broadband Inc. (AABB), closed Thursday’s trading session at $0.18, off by 3.2258%, on 11,546,529 volume. The average volume for the last 3 months is 11.547M and the stock's 52-week low/high is $0.0041/$0.659.

Recent News


The QualityStocks Daily Newsletter would like to spotlight SPYR Inc. (OTCQB: SPYR).

SPYR (OTCQB: SPYR), dba SPYR Technologies, develops and resells products that are compatible with the Apple(R) ecosystem through its Applied MagiX Inc. subsidiary. “In 2020, SPYR acquired Applied MagiX, a registered Apple developer and reseller of Apple ecosystem compatible products with an emphasis on the smart home market, as a wholly owned subsidiary. Applied MagiX operates in the IoT market and, more specifically, the segment related to the development, manufacture and sale of devices and accessories specifically built on Apple’s HomeKit(R) framework. These products work within the Apple HomeKit ecosystem and are exclusive to the Apple market and its consumers,” reads a recent article. The piece indicates that, while working to develop, manufacture and sell its own line of branded products, Applied MagiX will initially be sourcing HomeKit products and accessories from worldwide manufacturers, vetting and selecting best-of-breed products, supporting and selling them directly to consumers. “The company focuses on Apple consumers — a target market with higher disposable income and a demonstrated willingness to pay a premium for quality products. By creating smart hardware and software solutions exclusively for Apple consumers, SPYR addresses a problem faced by that market — having few ‘smart’ devices that integrate with Apple’s HomeKit, despite being the most affluent and loyal consumers of tech products.” To view the full article, visit

SPYR Inc. (OTCQB: SPYR), dba SPYR Technologies, is a technology company which, through its Applied MagiX Inc. subsidiary, develops and resells Apple®-ecosystem-compatible products with an emphasis on the growing, multibillion-dollar Internet of Things (IoT) Smart Home and Connected Car markets.

SPYR continues to identify and target acquisitions with an aim of growing its footprint in the industry and expanding the products it offers consumers, including companies developing artificial intelligence and smart-technology products. In 2020, SPYR acquired Applied MagiX Inc., a registered Apple developer and reseller of Apple ecosystem compatible products with an emphasis on the smart home market, as a wholly owned subsidiary. Applied MagiX operates in the IoT market and, more specifically, the segment of the market related to the development, manufacture and sale of devices and accessories specifically built on Apple’s HomeKit® framework. These products work within the Apple HomeKit ecosystem and are exclusive to the Apple market and its consumers.

Initially, while working to develop, manufacture and sell its own line of branded products, Applied MagiX will be sourcing HomeKit products and accessories from worldwide manufacturers, vetting and selecting best-of-breed products, selling them directly to consumers and supporting them. The company focuses on Apple consumers – a target market with higher disposable income and a demonstrated willingness to pay a premium for quality products. On average, Apple product users spend roughly twice as much on technology as other smartphone users. Those who purchase smart home products spend more than $3,000 on average.

By creating smart hardware and software solutions exclusively for Apple consumers, SPYR addresses a problem faced by that market – having few “smart” devices that integrate with Apple’s HomeKit, despite being the most affluent and loyal consumers of tech products.


The company’s Applied MagiX subsidiary offers multiple product lines to its target markets. First, the subsidiary is a reseller of third-party manufactured Apple HomeKit and Apple CarPlay compatible products. HomeKit comes pre-installed on every new iPhone, while the CarPlay platform is licensed by all major auto manufacturers. Applied MagiX identifies white label products, applies the company’s branding, improves the software and sells these improved products to consumers. Finally, Applied MagiX is developing its own proprietary line of smart home and connected car products, including Apple-compatible home cameras, sensors and alarms, as well as additional Apple-compatible smart car products in the iOS ecosystem.

Among the subsidiary’s products sold to consumers are:

  • The MagixDrive Wireless CarPlay adapter, which allows users to access CarPlay wirelessly using their iPhones
  • The HomeKit Secure Video Camera with iCloud Storage
  • The Multipurpose Sensor with Alarm
  • The Environment and Motion Sensor
  • The Window and Door Contact Sensor

Market Outlook

According to Statista, the global smart home market is expected to generate revenue of more than $104 billion in 2021. The market is forecast to hit more than $187 billion in revenue by 2025, recording a CAGR of 15.75 percent.

The number of active households in the worldwide smart home market is expected to reach nearly 500 million by 2025. Household penetration is just over 12 percent in 2021 and is projected to nearly double by 2025 to more than 22 percent.

Allied Market Research valued the global connected car market at more than $63 billion in 2019 and projected a CAGR of 17.1 percent, which would push revenue to more than $225 billion by 2027. Allied identified rising consumer demand for connectivity solutions, surging need for constant connectivity, increasing dependency on technology and an upsurge in tech-savvy population as key factors driving the projected growth of the connected car market.

Management Team

James R. Thompson is the CEO, President and General Counsel of SPYR. Over the past 28 years, Mr. Thompson has deftly managed a colorful spectrum of legal clients and situations. In the process, he has helped many companies – both large and small – thrive. Now he welcomes the challenge to take the company and his career in an entirely new direction. A native of Philadelphia, he holds a J.D. from Rutgers University and a Bachelor of Science from the University of Denver.

Jennifer Duettra is the Executive Vice President of SPYR. She brings a great deal of knowledge in mobile gaming and pop culture to the company. She is an attorney and was thrilled by the prospect to combine her law experience with a chance to be creative. She is a native of Colorado and received her Bachelor of Arts in Political Science and Speech Communication from Colorado State University. She holds a J.D. from Harvard University.

Trang Nguyen is the CFO of SPYR. From 2019 to 2020, she served as the Financial Reporting Manager for Del Taco, where she was responsible for the preparation and filing of periodic financial reports with the U.S. Securities and Exchange Commission. From 2016 through 2019, Ms. Nguyen was Accounting Manager for Pinnacle Tax Accounting in Los Angeles, California. She was a part of Ernst & Young’s audit team in Los Angeles from 2006 to 2008, leading engagements on interim and year-end ad SOX 404 auditing procedures for major enterprise accounts. Ms. Nguyen holds a Bachelor of Art, Business Economics (Minor in Accounting) from the University of California, Los Angeles. She is a certified public accountant with an inactive license.

Dr. Harald Zink is the CEO, Founder and Chief Product Architect of SPYR subsidiary Applied MagiX. Prior to founding Applied MagiX, he was Director of Technologies and later Vice President of Technologies at Sarkissian Productions in Los Angeles. He also served as Director of Technologies at SMZ Technologies and, for more than 17 years, as Macintosh Technology Consultant to The Walt Disney Studios in Burbank, California. He speaks five languages and holds degrees from the University of California, Riverside.

Kelly Clark is the COO of Applied MagiX. Before joining the subsidiary, he worked as Vice President of Sales Operations at TruClear Global. Prior to that, Mr. Clark was Senior Director of Program Management at Pacific Group Ventures and Operations Manager at Barco. He has also held operations management positions at Deluxe Digital Studios and Sony Pictures Entertainment. Mr. Clark holds a bachelor’s degree in international business from the University of Southern California.

SPYR Inc. (OTCQB: SPYR), closed Thursday’s trading session at $0.0447, off by 0.886918%, on 39,684 volume. The average volume for the last 3 months is 39,684 and the stock's 52-week low/high is $0.0321/$0.231.

Recent News

Moon Equity Holdings Corp. (OTC: MONI)

The QualityStocks Daily Newsletter would like to spotlight Moon Equity Holdings Corp. (MONI).

Moon Equity Holdings (OTC: MONI) today announced that it will soon launch a new product, which the company believes is the first-of-its-kind for the crypto industry. According to the update, the product offers unique features and enables the exchange and growth appreciation of crypto. Moon Equity Holdings is currently building a specialized website and backend system for the product and has additionally completed the acquisition of the BitGift card, with trademark details to be disclosed in the company’s financials. To be available as a virtual or actual physical card for customers, the company looks forward to the pending launch of the new product, which has been in the works for quite some time. To view the full press release, visit

Moon Equity Holdings Corp. (OTC: MONI) is an investment company that focuses on acquisitions in the fintech, crypto, precious metals and real estate sectors. The company’s goal is to enhance the profitability of these acquired companies, which in turn will increase shareholder value. Moon Equity Holdings’ philosophy is to provide its shareholders with a well-diversified acquisition portfolio focused on income-generating strategies that produce long term gains.

The company has been working on a crypto component in development, along with two trademarked products that will revolutionize how people gift and purchase cryptocurrency. With this, Moon Equity Holdings will use decentralized technology to enhance customer experience. First-rate service is the cornerstone of Moon Equity Holdings’ success. The company’s focus on best-in-class customer service is expected to create a loyal brand following and generate repeat business.

Business Operations

Moon Equity Holdings Corp. acquired Royal Costino LLC as a wholly owned subsidiary for its newly created Mining Division. Its primary business is processing, buying, selling and exporting precious metals. This acquisition completes the first step of the two planned mining acquisitions for this year. The acquisition is expected to significantly enhance revenue for the company, generating an estimated $2 million per month in additional income. Royal Costino’s facility has been in operation since 2013, and its team has more than 30 years of experience in this field.

Management Team

Moon Equity Holdings Corp. has assembled a highly skilled and experienced management team.

Alison Galardi is the CEO of Moon Equity Holdings Corp. Before joining the company, she gained more than 20 years of experience at Fortune 100 financial services companies, including Spear Leeds & Kellogg, TIAA-CREF and Citigroup, where she held positions in global banking, institutional sales, trading and investor relations.

Anthony Cappaze is head of Moon Equity Holdings’ Mining Division with more than 30 years of mining experience. He was founder and CEO of Royal Sovereign Costino prior to its acquisition by Moon Equity Holdings Corp.

Advisory Board

Sue Ferrari is a Senior Industry Principal that has over 20 years of experience in innovation, insights and analytics across technology, financial services and media, including VP, Bank of NY Mellon and ADP.

Maureen Vizvary worked at Microsoft, HP and Xerox launching innovative products and developing marketing campaigns that rebrand entire organizations. During her tenure at Microsoft, she served on the advisory team restructuring Microsoft’s mid-market sales division and developed award-winning, cutting-edge technology to transform the way hospitals interact with patient information.

Colleen Cline has over 33 years’ experience in the financial services and insurance industries, including sales, marketing, business development and management. She worked with Fifth Third Bancorp and Allstate Insurance, receiving various industry awards in sales, marketing and customer satisfaction. She is also an entrepreneur and top performer in the health care and wellness industry.

Moon Equity Holdings Corp. (OTC: MONI), closed Thursday’s trading session at $0.018, off by 21.7391%, on 12,660,448 volume. The average volume for the last 3 months is 12.66M and the stock's 52-week low/high is $0.00205/$0.14654.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading